A study led by researchers from MD Anderson Cancer Center showed a significant overall survival benefit with ribociclib plus endocrine therapy for postmenopausal patients with hormone receptor-positive (HR+) human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer.
A UTHealth-led study found increases in both men and women for several HPV-related cancers in low-income counties or those with high smoking rates. Increases were slower in the highest-income U.S. counties, or those with low smoking rates.
Vanderbilt study: World Trade Center responders at higher risk for blood cancer-associated mutations
Scientists from Vanderbilt-Ingram Cancer Center and researchers from New York determined that 9/11 first responders to the World Trade Center have increased levels of mutations that escalate their risk for blood cancers or cardiovascular disease.
Researchers from NYU Grossman School of Medicine and NYU’s Laura and Isaac Perlmutter Cancer Center found that amyloid beta, a protein known to build-up in the brains of Alzheimer’s patients, helps melanoma cells thrive when they have spread to the brain. The study authors focused on melanoma because it metastasizes to the brain in 40% of patients with stage IV disease.
A COVID-19 investigational vaccine, developed by City of Hope scientists and now licensed to GeoVax Labs Inc., produced a robust neutralizing antibody and T cell response against SARS-CoV-2 with no significant side effects in a phase I clinical trial led by John Zaia, Aaron D. Miller and Edith Miller Chair for Gene Therapy.
Boston Cell Standards has established the Consortium for Analytic Standardization in Immunohistochemistry. The organization is led by an international panel of pathologists and scientists focused on improving patient immunohistochemistry test accuracy and reproducibility.
Cancer Support Community and the Colorectal Cancer Alliance have partnered to expand CSC’s flagship research study, the Cancer Experience Registry.
The Barbara Ann Karmanos Cancer Institute and Lifeguard Health Networks will collaborate to pilot a connected care program that provides patients and caregivers an integrated digital care platform to help them manage cancer care at home.
A Harvard and Massachusetts General Hospital study found that an artificial intelligence model incorporating multiple methods of machine learning accurately detects thyroid cancer and predicts pathological and genomic outcomes through analysis of routine ultrasound images.
A phase II trial led by University of Michigan researchers found that PET scans obtained before and midway through treatment for p16-positive oropharynx cancer (OPC) can help determine whether a patient can receive a lower dose of radiation therapy in the second half of their treatment course without compromising cancer control.
